Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Vizient, Inc.

< Previous 1 2 3 4 5 Next >
Vizient Recognizes Suppliers and Distributors for Service Excellence
From Vizient, Inc.
Via Business Wire
Vizient Hosts Congressional Briefing on Rural Healthcare
From Vizient, Inc.
Via Business Wire
Vizient Expert to Moderate Panel at FDA’s Compounding Quality Center of Excellence Conference
From Vizient, Inc.
Via Business Wire
Sg2's New Data Solution Unlocks Market Share Insights for Healthcare Organizations
From Vizient, Inc.
Via Business Wire
Vizient Completes Acquisition of Kaufman Hall, Consolidates Strategic Advisory Services for the Healthcare Industry
From Vizient, Inc.
Via Business Wire
Vizient Projects Drug Price Inflation at 3.81%
From Vizient, Inc.
Via Business Wire
Vizient Agreement With Greenly Enhances Greenhouse Gas Data Collection Solution for Providers and Suppliers
From Vizient, Inc.
Via Business Wire
Vizient to Acquire Kaufman Hall, Expanding Advisory Expertise for Healthcare Industry
From Vizient, Inc.
Via Business Wire
Vizient examines pulsed field ablation, wearables for women’s cardiovascular health in latest Medical Device Tech Watch
From Vizient, Inc.
Via Business Wire
Vizient’s Corporate Responsibility Report Highlights Positive Impacts on People, Places and the Planet
From Vizient, Inc.
Via Business Wire
Vizient Showcases Vizient Vulnerability Index™ on Capitol Hill
From Vizient, Inc.
Via Business Wire
Sg2 Projects Continued Constraints for Patient Access to Care
From Vizient, Inc.
Via Business Wire
Vizient report finds behavioral health Medicaid patients under-treated compared to commercially insured patients
From Vizient, Inc.
Via Business Wire
Vizient Hosts Congressional Briefing on Medicare Advantage
From Vizient, Inc.
Via Business Wire
Vizient/AACN Nurse Residency Program announces integration of Maryland R3 curriculum
From Vizient, Inc.
Via Business Wire
Vizient conducts first Insight: Cell, Gene, and Specialty Pharmacy Symposium
From Vizient, Inc.
Via Business Wire
Fortune Media and Great Place To Work Name Vizient to ‘100 Best Companies to Work For’ in 2024
From Vizient, Inc.
Via Business Wire
Vizient Task Force Releases Recommendations for Hospitals on Preparing for an Active Shooter Event
From Vizient, Inc.
Via Business Wire
Vizient Announces Trends for Providers to Strategize in 2024
From Vizient, Inc.
Via Business Wire
Vizient Now Accepting Applications for 2024 Innovative Technology Exchange
From Vizient, Inc.
Via Business Wire
Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals
From Vizient, Inc.
Via Business Wire
Vizient Explores Cardiac Ablation Modalities, Advancements in Remote Patient Monitoring and Imaging Alternatives for Early Breast Cancer Detection
From Vizient, Inc.
Via Business Wire
For Pediatric Patient Population, Vizient Forecasts Growth in Obesity Services, Highlights Risk Factors for Asthma and Examines New RSV Vaccines
From Vizient, Inc.
Via Business Wire
Vizient Hosts Congressional Briefing on Mental and Behavioral Health
From Vizient, Inc.
Via Business Wire
Vizient Announces Acquisition of PrefTech OR, a Next-generation Physician Preference Card Management Technology
From Vizient, Inc.
Via Business Wire
Vizient Announces Top Performers in Clinical Quality, Supplier Diversity and Environmentally Preferred Sourcing Excellence
From Vizient, Inc.
Via Business Wire
Vizient Recognizes 22 Suppliers and Distributors for Service Excellence
From Vizient, Inc.
Via Business Wire
Vizient Examines Strategies to Retain Musculoskeletal Procedure Volume as Care Sites Shift
From Vizient, Inc.
Via Business Wire
Vizient Report on Chronic Kidney Disease Finds Wide Variation in Rate of Screening Among Patient Populations Affecting Outcomes
From Vizient, Inc.
Via Business Wire
Vizient Releases 2022 Diversity, Equity and Inclusion (DEI) Report
From Vizient, Inc.
Via Business Wire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.